Habitat Escalated Adaptive Therapy (HEAT): A Phase 2 Trial Utilizing Radiomic Habitat-Directed and Genomic-Adjusted Radiation Dose (GARD) Optimization for High-Grade Soft Tissue Sarcoma

Autor: Naghavi, A.O., Costello, J., Kim, Y., Joyce, D., Ahmed, K.A., Redler, G., Yang, G.Q., Rosenberg, S.A., Bryant, J.M., Bui, M.M., Henderson-Jackson, E.B., Gonzalez, R.J., Binitie, O., Lazarides, A., Mullinax, J., Feygelman, V., Ahmed, A.F., Parikh, N., Torres-Roca, J.F., Latifi, K.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 October 2024 120(2) Supplement:S88-S89
Databáze: ScienceDirect